subcutaneous Tecentriq
![Roche, Tecentriq, subcutaneous injection, subcutaneous Tecentriq, FDA setback, immunotherapy](https://pharmtales.com/wp-content/uploads/2023/09/Roches-subcutaneous-Tecentriq-faces-FDA-setback-due-to-manufacturing-updates.jpg)
Rocheās subcutaneous Tecentriq faces FDA setback due to manufacturing updates
Anika Sharma
Roche may experience a delay in the FDA decision for its subcutaneous version of the cancer immunotherapy Tecentriq, as it ...
Roche may experience a delay in the FDA decision for its subcutaneous version of the cancer immunotherapy Tecentriq, as it ...